SheerVision, Inc. (SVSO)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2009 | 1.43 Million USD | 17.08% |
| 2008 | 1.22 Million USD | 62.94% |
| 2007 | 750.34 Thousand USD | 106.57% |
| 2006 | 363.23 Thousand USD | 929.73% |
| 2005 | 35.27 Thousand USD | 31.89% |
| 2004 | 26.74 Thousand USD | 25.21% |
| 2003 | 21.36 Thousand USD | -19.62% |
| 2002 | 26.57 Thousand USD | -22.86% |
| 2001 | 34.45 Thousand USD | 53.11% |
| 2000 | 22.5 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2010 Q2 | 1.97 Million USD | 45.25% |
| 2010 Q3 | 1.65 Million USD | -16.17% |
| 2010 Q1 | 1.36 Million USD | -4.85% |
| 2009 Q2 | 1.13 Million USD | -11.59% |
| 2009 Q4 | 1.43 Million USD | 13.07% |
| 2009 Q3 | 1.26 Million USD | 11.14% |
| 2009 FY | 1.43 Million USD | 17.08% |
| 2009 Q1 | 1.28 Million USD | 5.39% |
| 2008 FY | 1.22 Million USD | 62.94% |
| 2008 Q1 | 879.91 Thousand USD | 17.27% |
| 2008 Q4 | 1.22 Million USD | 1.67% |
| 2008 Q3 | 1.2 Million USD | 30.45% |
| 2008 Q2 | 921.8 Thousand USD | 4.76% |
| 2007 Q2 | 678.11 Thousand USD | 43.82% |
| 2007 Q3 | 748.77 Thousand USD | 10.42% |
| 2007 FY | 750.34 Thousand USD | 106.57% |
| 2007 Q4 | 750.34 Thousand USD | 0.21% |
| 2007 Q1 | 471.48 Thousand USD | 29.8% |
| 2006 FY | 363.23 Thousand USD | 929.73% |
| 2006 Q4 | 363.23 Thousand USD | -90.89% |
| 2006 Q3 | 3.98 Million USD | 109.13% |
| 2006 Q2 | 1.9 Million USD | 0.0% |
| 2006 Q1 | - USD | -100.0% |
| 2005 Q1 | 26.11 Thousand USD | -10.39% |
| 2005 FY | 35.27 Thousand USD | 31.89% |
| 2005 Q4 | 41.87 Thousand USD | 18.71% |
| 2005 Q2 | 27.61 Thousand USD | 5.74% |
| 2005 Q3 | 35.27 Thousand USD | 27.72% |
| 2004 FY | 26.74 Thousand USD | 25.21% |
| 2004 Q4 | 29.14 Thousand USD | 8.98% |
| 2004 Q3 | 26.74 Thousand USD | -7.98% |
| 2004 Q2 | 29.06 Thousand USD | 11.87% |
| 2004 Q1 | 25.98 Thousand USD | 13.13% |
| 2003 Q3 | 21.36 Thousand USD | -35.25% |
| 2003 Q1 | 31.49 Thousand USD | -39.78% |
| 2003 FY | 21.36 Thousand USD | -19.62% |
| 2003 Q2 | 32.99 Thousand USD | 4.76% |
| 2003 Q4 | 22.96 Thousand USD | 7.51% |
| 2002 Q3 | 26.57 Thousand USD | -6.62% |
| 2002 Q1 | 22.54 Thousand USD | -51.16% |
| 2002 Q4 | 52.29 Thousand USD | 96.78% |
| 2002 Q2 | 28.45 Thousand USD | 26.23% |
| 2002 FY | 26.57 Thousand USD | -22.86% |
| 2001 Q1 | 27 Thousand USD | 14.89% |
| 2001 Q2 | 29.25 Thousand USD | 8.33% |
| 2001 Q3 | 34.45 Thousand USD | 17.78% |
| 2001 Q4 | 46.16 Thousand USD | 34.0% |
| 2001 FY | 34.45 Thousand USD | 53.11% |
| 2000 Q1 | 15 Thousand USD | 0.0% |
| 2000 Q4 | 23.5 Thousand USD | 4.44% |
| 2000 Q3 | 22.5 Thousand USD | 50.0% |
| 2000 FY | 22.5 Thousand USD | 0.0% |
| 2000 Q2 | 15 Thousand USD | 0.0% |
| 1999 Q4 | 15 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | 39.085% |
| Ansell Limited | 1.32 Billion USD | 99.892% |
| Ansell Limited | 1.33 Billion USD | 99.893% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | 98.867% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -51.765% |
| Psykey, Inc. | 2.47 Million USD | 42.143% |
| ConvaTec Group Plc | 2.01 Billion USD | 99.929% |
| ConvaTec Group Plc | 2.02 Billion USD | 99.929% |
| Encision Inc. | 1.98 Million USD | 27.852% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | 52.922% |
| Innovative MedTech Inc. | 6.13 Million USD | 76.668% |
| LifePoint, Inc. | 2.45 Million USD | 41.675% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | 85.94% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | 57.9% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | 52.919% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -84.381% |
| SmileDirectClub, Inc. | 982.26 Million USD | 99.854% |
| Sector 10, Inc. | 9.84 Million USD | 85.461% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | 99.894% |
| United Health Products, Inc. | 1.99 Million USD | 28.389% |
| Vasamed, Inc. | 1 Million USD | -42.386% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | 62.334% |
| Yubo International Biotech Limited | 2.91 Million USD | 50.877% |